SynthesisFrontiers in oncology2026
Visualizing research on the prognosis of papillary thyroid cancer: a bibliometric analysis.
Synthesis in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Over the last two decades, the prognosis of papillary thyroid cancer (PTC) has attracted increasing research attention, highlighting its vital role in improving patient outcomes. However, despite the multitude of studies, comprehensive bibliometric analyses concentrating specifically on PTC prognosis are still scarce. Methods: Our study involved a bibliometric analysis of 3,430 articles related to PTC prognosis, derived from the Web of Science Core Collection (WOSCC) database. We utilized VOSviewer, CiteSpace, and the R package "bibliometrix" to examine publication trends, identify key contributing countries and institutions, map collaborative networks, recognize prominent journals, and scrutinize both high-frequency keywords and highly cited references. Results: From 2004 to 2024, the number of research articles on the prognosis of PTC steadily increased, with a total of 3,430 articles included in our analysis. The year 2022 marked the peak in the number of publications, with 325 articles being published. China and the United States are at the forefront in terms of publication volume and citations, albeit with a slightly lower citation rate for China. Notable contributions also emerge from South Korea, Italy, and Japan. Collaboration is predominantly observed among the leading nations, with developing countries engaging less frequently. Prominent institutions such as Kuma Hospital in Japan and Shanghai Jiao Tong University in China stand out in terms of publication output. The journals "Thyroid," "Frontiers in Endocrinology," and "World Journal of Surgery" lead the field, with "Thyroid" boasting the highest co-citation rate. The keyword analysis revealed six primary research clusters, focusing on cell and molecular biology, oncology-related terminology, risk factors, disease progression, and clinical treatment approaches. The highly cited articles underscore the significant impact of BRAF V600E mutations on PTC prognosis. Conclusion: This study offers an in-depth overview of prevailing research hotspots and trends, providing pivotal insights to direct future research endeavors and enhance prognostic care for PTC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.